# Effectiveness of Intranasal Versus Intravenous Fentanyl in Preterm and Term Newborns for Pain Prevention

> **NCT02125201** · PHASE4 · COMPLETED · sponsor: **HaEmek Medical Center, Israel** · enrollment: 21 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT02125201
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2018-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02125201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02125201, "Effectiveness of Intranasal Versus Intravenous Fentanyl in Preterm and Term Newborns for Pain Prevention". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02125201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*